In the present study, we note three major findings indicating that kefir peptides alleviate PM4.0-induced pulmonary inflammation in NF-κB-luciferase+/+ transgenic mice through NF-κB pathway inhibition. This evidence concerns the gene NFKB1 and inflammatory response.